Watch: Redefining AAV Quality Control in Cell and Gene Therapy Development & Manufacturing
With the rapid adoption of NanoMosaic Tessie for in-process AAV capsid and transgene quantification with unparalleled analytical depth, we’re bringing together three leading cell and gene therapy experts to discuss their vision for comprehensive gene therapy characterization and improved decision-making.
Join Guangping Gao, Director, Horae Gene Therapy Center, and Viral Vector Core at Mass Chan Medical School, Daniel Hurwit, Senior Principal Scientist at Bristol Myers Squibb, and Patrick Starremans, Solid Biosciences Head of Analytical Sciences, as they explore key aspects of this groundbreaking field and answer your questions in a live Q&A session.
Watch it now
Watch: Redefining AAV Quality Control in Cell and Gene Therapy Development & Manufacturing
With the rapid adoption of NanoMosaic Tessie for in-process AAV capsid and transgene quantification with unparalleled analytical depth, we’re bringing together three leading cell and gene therapy experts to discuss their vision for comprehensive gene therapy characterization and improved decision-making.
Join Guangping Gao, Director, Horae Gene Therapy Center, and Viral Vector Core at Mass Chan Medical School, Daniel Hurwit, Senior Principal Scientist at Bristol Myers Squibb, and Patrick Starremans, Solid Biosciences Head of Analytical Sciences, as they explore key aspects of this groundbreaking field and answer your questions in a live Q&A session.